Kirin Health Innovation Fund

Overview

The Kirin Health Innovation Fund (KHIF) is a corporate venture capital fund established by Kirin Holdings Company, Limited, in partnership with Global Brain Corporation. The fund focuses on investing in startups worldwide that operate in the health science domain, aiming to leverage innovative technologies and business models to address health issues and enhance customer experiences. By combining Kirin Holdings' expertise in health science with the innovations brought by startups, KHIF seeks to strengthen existing businesses and create new ventures in the health science sector. KHIF considers a wide range of investment stages, from seed to late-stage companies, and has a flexible approach to investment sizes, with individual investments ranging from tens to 100 million Japanese yen, up to a maximum of 500 million Japanese yen per case. The fund's geographical focus includes both domestic and international markets, reflecting its commitment to fostering global partnerships in the health science field. Through its strategic investments, KHIF aims to contribute to the realization of affluent lifestyles where people can maintain health naturally, aligning with Kirin Holdings' vision to be a lifestyle partner in the age of 100 years of life. The fund's diverse portfolio includes companies specializing in areas such as biotechnology, pharmaceuticals, medical devices, digital health, and health IT, demonstrating its broad commitment to advancing health science innovations.

Investment Focus

• Innovative technologies and business models addressing health issues
• Potential for global impact
• Alignment with Kirin Holdings' health science domain

Portfolio Companies